As Macrogenics (MGNX) Share Price Rose, Bb Biotech Ag Has Lifted by $3.80 Million Its Holding; Arista Networks (ANET) Holder Origin Asset Management Llp Has Lowered Its Holding

Arista Networks, Inc. (NYSE:ANET) Logo

Bb Biotech Ag increased its stake in Macrogenics Inc. (MGNX) by 8.33% based on its latest 2017Q4 regulatory filing with the SEC. Bb Biotech Ag bought 200,000 shares as the company’s stock rose 22.09% while stock markets declined. The institutional investor held 2.60 million shares of the health care company at the end of 2017Q4, valued at $49.41 million, up from 2.40 million at the end of the previous reported quarter. Bb Biotech Ag who had been investing in Macrogenics Inc. for a number of months, seems to be bullish on the $989.12 million market cap company. The stock increased 1.21% or $0.28 during the last trading session, reaching $23.44. About 200,038 shares traded. MacroGenics, Inc. (NASDAQ:MGNX) has risen 31.18% since April 29, 2017 and is uptrending. It has outperformed by 19.63% the S&P500.

Origin Asset Management Llp decreased its stake in Arista Networks Inc (ANET) by 34.95% based on its latest 2017Q4 regulatory filing with the SEC. Origin Asset Management Llp sold 66,900 shares as the company’s stock rose 7.25% while stock markets declined. The institutional investor held 124,535 shares of the technology company at the end of 2017Q4, valued at $29.34M, down from 191,435 at the end of the previous reported quarter. Origin Asset Management Llp who had been investing in Arista Networks Inc for a number of months, seems to be less bullish one the $19.54B market cap company. The stock increased 1.25% or $3.24 during the last trading session, reaching $262.75. About 721,891 shares traded. Arista Networks, Inc. (NYSE:ANET) has risen 91.94% since April 29, 2017 and is uptrending. It has outperformed by 80.39% the S&P500.

Since January 16, 2018, it had 0 insider purchases, and 7 selling transactions for $1.10 million activity. Cilinski Lynn had sold 23,967 shares worth $599,436 on Wednesday, February 28. Wigginton Jon Marc sold 5,000 shares worth $100,000. Shares for $155,000 were sold by Karrels James.

Investors sentiment decreased to 1.11 in 2017 Q4. Its down 0.47, from 1.58 in 2017Q3. It fall, as 14 investors sold MGNX shares while 31 reduced holdings. 15 funds opened positions while 35 raised stakes. 28.26 million shares or 1.97% more from 27.72 million shares in 2017Q3 were reported. 10,515 are owned by Muhlenkamp & Co. Amer Int Inc has invested 0% in MacroGenics, Inc. (NASDAQ:MGNX). Vanguard Gru Incorporated owns 0% invested in MacroGenics, Inc. (NASDAQ:MGNX) for 1.56 million shares. Alliancebernstein Limited Partnership holds 43,000 shares or 0% of its portfolio. Northern Corp has 432,223 shares for 0% of their portfolio. 14,466 are owned by Tudor Corp Et Al. Legal General Group Incorporated Pcl reported 8,986 shares or 0% of all its holdings. Ameriprise Finance Incorporated holds 0% or 84,894 shares in its portfolio. Group One Trading LP holds 0% of its portfolio in MacroGenics, Inc. (NASDAQ:MGNX) for 1,213 shares. Ameritas Inv Prtnrs reported 0% in MacroGenics, Inc. (NASDAQ:MGNX). Principal Fincl accumulated 83,606 shares or 0% of the stock. State Board Of Administration Of Florida Retirement Sys invested in 0% or 17,011 shares. Private Inc has 17,500 shares. Eventide Asset Mngmt Limited holds 0.15% of its portfolio in MacroGenics, Inc. (NASDAQ:MGNX) for 147,000 shares. Renaissance Technology Ltd Liability Corporation owns 300,523 shares for 0.01% of their portfolio.

Bb Biotech Ag, which manages about $3.55 billion US Long portfolio, decreased its stake in Juno Therapeutics Inc. (NASDAQ:JUNO) by 130,000 shares to 1.93 million shares, valued at $87.99M in 2017Q4, according to the filing. It also reduced its holding in Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) by 60,000 shares in the quarter, leaving it with 1.05M shares, and cut its stake in Sage Therapeutics Inc. (NASDAQ:SAGE).

Among 11 analysts covering MacroGenics (NASDAQ:MGNX), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. MacroGenics had 25 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of MacroGenics, Inc. (NASDAQ:MGNX) has “Buy” rating given on Monday, September 11 by Stifel Nicolaus. SunTrust maintained MacroGenics, Inc. (NASDAQ:MGNX) on Friday, September 1 with “Buy” rating. The firm has “Buy” rating by Leerink Swann given on Friday, April 6. Janney Capital initiated MacroGenics, Inc. (NASDAQ:MGNX) rating on Thursday, February 18. Janney Capital has “Buy” rating and $36 target. Citigroup downgraded MacroGenics, Inc. (NASDAQ:MGNX) rating on Thursday, August 4. Citigroup has “Neutral” rating and $32 target. Morgan Stanley maintained the shares of MGNX in report on Monday, August 7 with “Equal-Weight” rating. SunTrust maintained the stock with “Buy” rating in Tuesday, January 23 report. Morgan Stanley maintained MacroGenics, Inc. (NASDAQ:MGNX) rating on Wednesday, March 14. Morgan Stanley has “Equal-Weight” rating and $26 target. The rating was upgraded by Citigroup to “Buy” on Monday, October 19. The stock has “Buy” rating by BTIG Research on Friday, January 19.

Among 36 analysts covering Arista Networks (NYSE:ANET), 18 have Buy rating, 1 Sell and 17 Hold. Therefore 50% are positive. Arista Networks had 127 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Buy” rating by Oppenheimer on Friday, July 14. The firm earned “Hold” rating on Tuesday, October 3 by Jefferies. The rating was maintained by Needham on Monday, October 31 with “Buy”. On Friday, February 16 the stock rating was maintained by Nomura with “Hold”. The firm has “Buy” rating given on Friday, May 5 by Oppenheimer. The stock of Arista Networks, Inc. (NYSE:ANET) earned “Hold” rating by Deutsche Bank on Tuesday, January 23. The firm has “Sector Perform” rating given on Wednesday, August 31 by RBC Capital Markets. As per Friday, February 17, the company rating was maintained by Needham. As per Friday, May 13, the company rating was initiated by JP Morgan. As per Friday, April 28, the company rating was downgraded by Credit Suisse.

Origin Asset Management Llp, which manages about $2.70B and $1.75 billion US Long portfolio, upped its stake in Thor Inds Inc (NYSE:THO) by 20,900 shares to 201,619 shares, valued at $30.39M in 2017Q4, according to the filing. It also increased its holding in Synnex Corp (NYSE:SNX) by 89,100 shares in the quarter, for a total of 166,768 shares, and has risen its stake in Applied Matls Inc (NASDAQ:AMAT).

Analysts await Arista Networks, Inc. (NYSE:ANET) to report earnings on May, 3 after the close. They expect $1.32 earnings per share, up 67.09% or $0.53 from last year’s $0.79 per share. ANET’s profit will be $98.16M for 49.76 P/E if the $1.32 EPS becomes a reality. After $1.45 actual earnings per share reported by Arista Networks, Inc. for the previous quarter, Wall Street now forecasts -8.97% negative EPS growth.

MacroGenics, Inc. (NASDAQ:MGNX) Institutional Positions Chart